Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis

Purpose Immune checkpoint inhibitor (ICI) therapy is often suspended because of immune-related enterocolitis (irEC). We examined the effect of resumption of ICIs with or without concurrent selective immunosuppressive therapy (SIT) on rates of symptom recurrence and survival outcomes.Methods This ret...

Full description

Bibliographic Details
Main Authors: Wei Qiao, John A Thompson, Hamzah Abu-Sbeih, Yinghong Wang, Michael Dougan, Mehmet Altan, Michael A Postow, Yousef R Badran, Fangwen Zou, Anusha S Thomas, Sienna M Durbin, Barbara E Dutra, Donna E Leet, Po-Ying Lai, Nora K Horick, David M Faleck
Format: Article
Language:English
Published: BMJ Publishing Group 2023-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/6/e007195.full

Internet

https://jitc.bmj.com/content/11/6/e007195.full

Similar Items